[ Price : $8.95]
Federal Register Notice: FDA plans a public meeting 11/10 on the labeling for lower-dose vaginal estrogen products intended to tre...[ Price : $8.95]
Federal Register Notice: FDA plans a public meeting 12/18 on the reauthorization of the Biosimilar User Fee Act for fiscal years 2...[ Price : $8.95]
FDA posts a new International Conference on Harmonization guidance entitled M7(R1) Addendum to ICH M7: Assessment and Control of D...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes regulations to describe when a product derived from tobacco will be subject to regula...[ Price : $8.95]
FDA approves Novo Nordisks Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to i...[ Price : $8.95]
The owner of Daniel Chapter One, James Feijo, pleads guilty in Providence, RI federal court to marketing and selling unapproved pr...[ Price : $8.95]
FDA approves revisions to Bristol-Myers Squibbs Reyataz (atazanavir) oral powder label to include dosing recommendations for patie...[ Price : $8.95]
FDA says it continues to be concerned that companies are still submitting citizen petitions that are intended primarily to delay t...